Long-Term Efficacy and Safety of Intravitreal Aflibercept Injections for the Treatment of Diabetic Retinopathy for Subjects Who Completed the 2-Year PANORAMA Trial
Condition(s):Diabetic RetinopathyLast Updated:August 21, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Diabetic RetinopathyLast Updated:August 21, 2023Active, not recruiting
Condition(s):Arthritis, RheumatoidLast Updated:February 22, 2019Terminated
Condition(s):FibromyalgiaLast Updated:January 16, 2019Completed
Condition(s):Prostate CancerLast Updated:March 18, 2024Active, not recruiting
Condition(s):Persistent Pregnancy of Unknown Location; Ectopic PregnancyLast Updated:December 8, 2020Completed
Condition(s):Breast Cancer Stage IVLast Updated:October 7, 2021Completed
Condition(s):Quality of Life; Brain Diseases; Depression; Physical ImpairmentLast Updated:June 4, 2020Completed
Condition(s):Cerebral Palsy, SpasticLast Updated:April 24, 2023Active, not recruiting
Condition(s):Diabetes; Diabetes Mellitus, Type 2; Medullary Thyroid Carcinoma; Weight ManagementLast Updated:June 13, 2023Enrolling by invitation
Condition(s):Infant, Small for Gestational AgeLast Updated:November 4, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.